From: Elimination of lymphatic filariasis as a public health problem in Niue under PacELF, 1999–2016
Year | Activity | Detail and location of activity |
---|---|---|
1999 | Baseline survey | Whole population mapping baseline survey (by ICT) |
Nationwide education and awareness campaign | ||
2000 | MDA1 | Nationwide MDA (combined DEC and albendazole) |
2001 | MDA2 | Nationwide MDA (combined DEC and albendazole) |
Mid-term survey | Mid-term whole population survey (ICT) | |
2002 | MDA3 | Nationwide MDA (combined DEC and albendazole) |
Follow-up | Testing (by ICT) of positive cases and treatment | |
2003 | MDA4 | Nationwide MDA (combined DEC and albendazole) |
Follow-up | Testing (by ICT) of positive cases and treatment | |
2004 | MDA5 | Final Nationwide MDA (combined DEC and albendazole) |
Stop MDA survey | Nationwide Survey by ICT in all ages | |
2006 | Follow-up | Follow-up of one +ve case undertaken |
2009 | Post MDA survey | Nationwide Post-MDA survey (by ICT all ages) |
Follow-up | +ve cases re-tested, re-treated every six months until negative | |
2012 | Dossier development | Dossier for the validation of elimination of LF prepared |
2013 | Dossier submission | Validation dossier submitted to WHO Review Group |
2016 | Elimination validation | Official acknowledgement received from WHO of the validation of elimination of LF as a public health problem |